Recruiting EMITT-1 (ERAP Mediated Immunopeptidome Targeting Trial - 1) NCT06923761 Conditions Adenocarcinoma, Advanced Solid Malignancy, Carcinoma, +28 more Locations GenesisCare Research — Adelaide, Australia Southern Oncology Clinical Research Unit (SOCRU) — Bedford Park, Australia Blacktown Hospital — Blacktown, Australia Kinghorn Cancer Centre (KCC) — Darlinghurst, Australia View all 29 locations View more locations Show fewer locations Loading locations... View Trial Details
Completed Safety, Tolerability & Potential Anti-cancer Activity of Increasing Doses of AZD5363 in Different Treatment Schedules NCT01226316 Conditions AKT1, Adnexal Diseases, Advanced Solid Malignancy, +46 more Locations Research Site — Los Angeles, California, United States Research Site — Stanford, California, United States Research Site — West Hollywood, California, United States Research Site — Aurora, Colorado, United States View all 34 locations View more locations Show fewer locations Loading locations... View Trial Details
Completed Open Label Phase 1 Study in Japan for Patient With Advanced Solid Malignancies NCT01353781 Conditions Advanced Solid Malignancy, Advanced Solid Tumor Locations Research Site — Chūōku, Japan View Trial Details
